Gary S. Roubin - 28 May 2024 Form 4 Insider Report for InspireMD, Inc. (NSPR)

Reporting relationship
Director
Issuer ticker
NSPR
Reported as of
28 May 2024
Net transaction value
+$42,345
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
30 May 2024, 17:20:04 UTC
Prior SEC filing
25 Jan 2024
Next SEC filing
10 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gary S. Roubin

Key filing fact

Gary S. Roubin filed Form 4 for InspireMD, Inc. (NSPR) on 30 May 2024.

Key facts

  • This page summarizes Gary S. Roubin's Form 4 filing for InspireMD, Inc. (NSPR).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 30 May 2024, 17:20.

Change

  • Previous filing in this sequence was filed on 25 Jan 2024.
  • Current net transaction value: +$42,345.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NSPR transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
$42,345
Shares
+30,625
Change %
+6.5%
Price
$1.38
Shares after
501,788
Date
28 May 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NSPR transaction Derivative

Series H Warrant (right to buy)

Exercise of in-the-money or at-the-money derivative security

Transaction value
$0
Shares
-30,625
Change %
-100%
Price
$0.000000*
Shares after
0
Date
28 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,625
Exercise price
$1.38
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .